OpenLB
Open Library of Bioscience
Advanced Search
Seminars in respiratory and critical care medicine
Apr, 2024;45 (2): 274-286.

New Guidelines for Severe Community-acquired Pneumonia.

Davide Calabretta, Ignacio Martìn-Loeches, Antoni Torres
Author Information
  1. Davide Calabretta: Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  2. Ignacio Martìn-Loeches: Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organisation (MICRO), St James's Hospital, Dublin, Ireland.
  3. Antoni Torres: Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.
PMID: 38428839 DOI: 10.1055/s-0043-1777797

Abstract

In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity.

MeSH Term

Humans
Anti-Bacterial Agents
Pneumonia
Community-Acquired Infections

Chemicals

Anti-Bacterial Agents
Review Journal Article
Article has an altmetric score of 303

Word Cloud

Created with Highcharts 10.0.0guidelines2023newEuropeanseverecommunity-acquiredpneumoniaprovidingclinicalpracticerecommendationsmanagementlife-threateninginfectioncharacterizedhighburdenmortalitymorbiditycostssocietyreviewarticleaimssummarizeprincipalevidencerelatedeightdifferentquestionscoveredalsohighlightingfutureperspectivesresearchactivityNewGuidelinesSevereCommunity-acquiredPneumonia

Similar Articles

Cited By